Companies House 2024-11-01 2025-10-31 2025-10-31 false true iso4217:GBP xbrli:pure NI656688 2023-11-01 2024-10-31 NI656688 2025-10-31 NI656688 2024-11-01 2025-10-31 NI656688 2024-10-31 NI656688 curr:PoundSterling 2024-11-01 2025-10-31 NI656688 uk-bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 NI656688 uk-bus:FRS102 2024-11-01 2025-10-31 NI656688 uk-bus:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 NI656688 uk-bus:AbridgedAccounts 2024-11-01 2025-10-31 NI656688 uk-bus:RegisteredOffice 2024-11-01 2025-10-31 NI656688 uk-bus:Director40 2024-11-01 2025-10-31 NI656688 uk-bus:Director1 2024-11-01 2025-10-31 NI656688 uk-bus:Director2 2024-11-01 2025-10-31 NI656688 uk-bus:Director3 2024-11-01 2025-10-31 NI656688 uk-bus:Director4 2024-11-01 2025-10-31 NI656688 uk-bus:Director5 2024-11-01 2025-10-31 NI656688 uk-bus:Director6 2024-11-01 2025-10-31 NI656688 uk-bus:Director7 2024-11-01 2025-10-31 NI656688 uk-bus:Director8 2024-11-01 2025-10-31 NI656688 uk-bus:Director9 2024-11-01 2025-10-31 NI656688 uk-bus:Director10 2024-11-01 2025-10-31 NI656688 uk-bus:Director11 2024-11-01 2025-10-31 NI656688 uk-bus:Director12 2024-11-01 2025-10-31 NI656688 uk-bus:Director13 2024-11-01 2025-10-31 NI656688 uk-bus:Director14 2024-11-01 2025-10-31 NI656688 uk-bus:Director15 2024-11-01 2025-10-31 NI656688 uk-bus:Director16 2024-11-01 2025-10-31 NI656688 uk-bus:Director17 2024-11-01 2025-10-31 NI656688 uk-bus:Director18 2024-11-01 2025-10-31 NI656688 uk-bus:Director19 2024-11-01 2025-10-31 NI656688 uk-bus:Director20 2024-11-01 2025-10-31 NI656688 uk-bus:CompanySecretary1 2024-11-01 2025-10-31 NI656688 core:AfterOneYear 2025-10-31 NI656688 core:AfterOneYear 2024-10-31 NI656688 core:WithinOneYear 2025-10-31 NI656688 core:WithinOneYear 2024-10-31 NI656688 core:WithinOneYear 2024-11-01 2025-10-31 NI656688 core:AfterOneYear 2025-10-31 NI656688 core:AfterOneYear 2024-10-31 NI656688 core:AfterOneYear 2024-11-01 2025-10-31 NI656688 core:ShareCapital 2025-10-31 NI656688 core:ShareCapital 2024-10-31 NI656688 core:SharePremium 2025-10-31 NI656688 core:SharePremium 2024-10-31 NI656688 core:OtherReservesSubtotal 2025-10-31 NI656688 core:OtherReservesSubtotal 2024-10-31 NI656688 core:RevaluationReserve 2025-10-31 NI656688 core:RevaluationReserve 2024-10-31 NI656688 core:RetainedEarningsAccumulatedLosses 2025-10-31 NI656688 core:RetainedEarningsAccumulatedLosses 2024-10-31 NI656688 core:Associate1 2024-11-01 2025-10-31 NI656688 core:Associate1 2024-10-31 NI656688 core:Associate1 2025-10-31 NI656688 core:Associate2 2024-11-01 2025-10-31 NI656688 core:Associate2 2024-10-31 NI656688 core:Associate2 2025-10-31 NI656688 core:Associate3 2024-11-01 2025-10-31 NI656688 core:Associate3 2024-10-31 NI656688 core:Associate3 2025-10-31 NI656688 core:Associate4 2024-11-01 2025-10-31 NI656688 core:Associate4 2024-10-31 NI656688 core:Associate4 2025-10-31 NI656688 core:Associate5 2024-11-01 2025-10-31 NI656688 core:Associate5 2024-10-31 NI656688 core:Associate5 2025-10-31 NI656688 core:Associate6 2024-11-01 2025-10-31 NI656688 core:Associate6 2024-10-31 NI656688 core:Associate6 2025-10-31 NI656688 core:Associate7 2024-11-01 2025-10-31 NI656688 core:Associate7 2024-10-31 NI656688 core:Associate7 2025-10-31 NI656688 core:Associate8 2024-11-01 2025-10-31 NI656688 core:Associate8 2024-10-31 NI656688 core:Associate8 2025-10-31 NI656688 core:Associate9 2024-11-01 2025-10-31 NI656688 core:Associate9 2024-10-31 NI656688 core:Associate9 2025-10-31 NI656688 core:Associate10 2024-11-01 2025-10-31 NI656688 core:Associate10 2024-10-31 NI656688 core:Associate10 2025-10-31 NI656688 core:Associate11 2024-11-01 2025-10-31 NI656688 core:Associate11 2024-10-31 NI656688 core:Associate11 2025-10-31 NI656688 core:Associate12 2024-11-01 2025-10-31 NI656688 core:Associate12 2024-10-31 NI656688 core:Associate12 2025-10-31 NI656688 core:Associate13 2024-11-01 2025-10-31 NI656688 core:Associate13 2024-10-31 NI656688 core:Associate13 2025-10-31 NI656688 core:Associate14 2024-11-01 2025-10-31 NI656688 core:Associate14 2024-10-31 NI656688 core:Associate14 2025-10-31 NI656688 core:Associate15 2024-11-01 2025-10-31 NI656688 core:Associate15 2024-10-31 NI656688 core:Associate15 2025-10-31 NI656688 core:Associate16 2024-11-01 2025-10-31 NI656688 core:Associate16 2024-10-31 NI656688 core:Associate16 2025-10-31 NI656688 core:Associate17 2024-11-01 2025-10-31 NI656688 core:Associate17 2024-10-31 NI656688 core:Associate17 2025-10-31 NI656688 core:Associate18 2024-11-01 2025-10-31 NI656688 core:Associate18 2024-10-31 NI656688 core:Associate18 2025-10-31 NI656688 core:Associate19 2024-11-01 2025-10-31 NI656688 core:Associate19 2024-10-31 NI656688 core:Associate19 2025-10-31 NI656688 core:Associate20 2024-11-01 2025-10-31 NI656688 core:Associate20 2024-10-31 NI656688 core:Associate20 2025-10-31 NI656688 core:Associate1 2024-11-01 2025-10-31 NI656688 core:Associate2 2024-11-01 2025-10-31 NI656688 core:Associate3 2024-11-01 2025-10-31 NI656688 core:Associate4 2024-11-01 2025-10-31 NI656688 core:Associate5 2024-11-01 2025-10-31 NI656688 core:Associate6 2024-11-01 2025-10-31 NI656688 core:Associate7 2024-11-01 2025-10-31 NI656688 core:Associate8 2024-11-01 2025-10-31 NI656688 core:Associate9 2024-11-01 2025-10-31 NI656688 core:Associate10 2024-11-01 2025-10-31 NI656688 core:Associate11 2024-11-01 2025-10-31 NI656688 core:Associate12 2024-11-01 2025-10-31 NI656688 core:Associate13 2024-11-01 2025-10-31 NI656688 core:Associate14 2024-11-01 2025-10-31 NI656688 core:Associate15 2024-11-01 2025-10-31 NI656688 core:Associate16 2024-11-01 2025-10-31 NI656688 core:Associate17 2024-11-01 2025-10-31 NI656688 core:Associate18 2024-11-01 2025-10-31 NI656688 core:Associate19 2024-11-01 2025-10-31 NI656688 core:Associate20 2024-11-01 2025-10-31 NI656688 uk-bus:Director1 1 2024-11-01 2025-10-31 NI656688 uk-bus:Director1 1 2024-10-31 NI656688 uk-bus:Director1 1 2025-10-31 NI656688 uk-bus:Director2 2 2024-11-01 2025-10-31 NI656688 uk-bus:Director2 2 2024-10-31 NI656688 uk-bus:Director2 2 2025-10-31 NI656688 uk-bus:Director1 3 2024-11-01 2025-10-31 NI656688 uk-bus:Director1 3 2024-10-31 NI656688 uk-bus:Director1 3 2025-10-31 NI656688 uk-bus:Director4 4 2024-11-01 2025-10-31 NI656688 uk-bus:Director4 4 2024-10-31 NI656688 uk-bus:Director4 4 2025-10-31 NI656688 uk-bus:Director5 5 2024-11-01 2025-10-31 NI656688 uk-bus:Director5 5 2024-10-31 NI656688 uk-bus:Director5 5 2025-10-31 NI656688 uk-bus:Director6 6 2024-11-01 2025-10-31 NI656688 uk-bus:Director6 6 2024-10-31 NI656688 uk-bus:Director6 6 2025-10-31 NI656688 uk-bus:Director7 7 2024-11-01 2025-10-31 NI656688 uk-bus:Director7 7 2024-10-31 NI656688 uk-bus:Director7 7 2025-10-31 NI656688 uk-bus:Director8 8 2024-11-01 2025-10-31 NI656688 uk-bus:Director8 8 2024-10-31 NI656688 uk-bus:Director8 8 2025-10-31 NI656688 uk-bus:Director9 9 2024-11-01 2025-10-31 NI656688 uk-bus:Director9 9 2024-10-31 NI656688 uk-bus:Director9 9 2025-10-31 NI656688 uk-bus:Director10 10 2024-11-01 2025-10-31 NI656688 uk-bus:Director10 10 2024-10-31 NI656688 uk-bus:Director10 10 2025-10-31 NI656688 uk-bus:Director11 11 2024-11-01 2025-10-31 NI656688 uk-bus:Director11 11 2024-10-31 NI656688 uk-bus:Director11 11 2025-10-31 NI656688 uk-bus:Director12 12 2024-11-01 2025-10-31 NI656688 uk-bus:Director12 12 2024-10-31 NI656688 uk-bus:Director12 12 2025-10-31 NI656688 uk-bus:Director13 13 2024-11-01 2025-10-31 NI656688 uk-bus:Director13 13 2024-10-31 NI656688 uk-bus:Director13 13 2025-10-31 NI656688 uk-bus:Director14 14 2024-11-01 2025-10-31 NI656688 uk-bus:Director14 14 2024-10-31 NI656688 uk-bus:Director14 14 2025-10-31 NI656688 uk-bus:Director15 15 2024-11-01 2025-10-31 NI656688 uk-bus:Director15 15 2024-10-31 NI656688 uk-bus:Director15 15 2025-10-31 NI656688 uk-bus:Director16 16 2024-11-01 2025-10-31 NI656688 uk-bus:Director16 16 2024-10-31 NI656688 uk-bus:Director16 16 2025-10-31 NI656688 uk-bus:Director17 17 2024-11-01 2025-10-31 NI656688 uk-bus:Director17 17 2024-10-31 NI656688 uk-bus:Director17 17 2025-10-31 NI656688 uk-bus:Director18 18 2024-11-01 2025-10-31 NI656688 uk-bus:Director18 18 2024-10-31 NI656688 uk-bus:Director18 18 2025-10-31 NI656688 uk-bus:Director19 19 2024-11-01 2025-10-31 NI656688 uk-bus:Director19 19 2024-10-31 NI656688 uk-bus:Director19 19 2025-10-31 NI656688 uk-bus:Director20 20 2024-11-01 2025-10-31 NI656688 uk-bus:Director20 20 2024-10-31 NI656688 uk-bus:Director20 20 2025-10-31 NI656688 1 2024-11-01 2025-10-31 NI656688 2 2024-11-01 2025-10-31 NI656688 3 2024-11-01 2025-10-31

# NEUROSOLV THERAPEUTICS LIMITED

## Company Registration Number:
NI656688 (Northern Ireland)

## Unaudited abridged accounts for the year ended 31 October 2025

## Period of accounts

## Start date: 01 November 2024

## End date: 31 October 2025

# NEUROSOLV THERAPEUTICS LIMITED

## Contents of the Financial Statements

for the Period Ended 31 October 2025

Balance sheet |
Notes |

# NEUROSOLV THERAPEUTICS LIMITED

## Balance sheet

As at 31 October 2025

| Notes | 2025 | 2024
--- | --- | --- | ---
|  | £ | £
Fixed assets
Intangible assets: | 3 | 66,031,975 | 66,031,975
Total fixed assets: |  | 66,031,975 | 66,031,975
Current assets
Cash at bank and in hand: |  | 45,302 | 24,180
Total current assets: |  | 45,302 | 24,180
Net current assets (liabilities): |  | 45,302 | 24,180
Total assets less current liabilities: |  | 66,077,277 | 66,056,155
Total net assets (liabilities): |  | 66,077,277 | 66,056,155
Capital and reserves
Called up share capital: |  | 24 | 24
Other reserves: |  | 66,151,413 | 66,128,131
Profit and loss account: |  | (74,160) | (72,000)
Shareholders funds: |  | 66,077,277 | 66,056,155

The notes form part of these financial statements

# NEUROSOLV THERAPEUTICS LIMITED

## Balance sheet statements

For the year ending 31 October 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 24 July 2026
and signed on behalf of the board by:

Name: Aidan Lynch
Status: Director

The notes form part of these financial statements

# NEUROSOLV THERAPEUTICS LIMITED

## Notes to the Financial Statements

for the Period Ended 31 October 2025

## 1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

## Valuation and information policy

At the Balance Sheet date the Company had available to it financial facilities in connection with the funding of the Companies clinical development program which had not been drawn down. Accordingly no amounts in respect of these facilities are recognized in these financial statements.

# NEUROSOLV THERAPEUTICS LIMITED

## Notes to the Financial Statements

for the Period Ended 31 October 2025

## 2. Employees

| 2025 | 2024
--- | --- | ---
Average number of employees during the period | 2 | 2

# NEUROSOLV THERAPEUTICS LIMITED

## Notes to the Financial Statements

for the Period Ended 31 October 2025

## 3. Intangible Assets

| Total
--- | ---
Cost | £
At 01 November 2024 | 66,031,975
At 31 October 2025 | 66,031,975
Amortisation |
At 01 November 2024 | 0
At 31 October 2025 | 0
Net book value |
At 31 October 2025 | 66,031,975
At 31 October 2024 | 66,031,975